CVRx (CVRX)
(Delayed Data from NSDQ)
$8.73 USD
+0.39 (4.68%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $8.72 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CVRX 8.73 +0.39(4.68%)
Will CVRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CVRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CVRX
CVRx (CVRX) Reports Q2 Loss, Lags Revenue Estimates
Intuitive Surgical, Inc. (ISRG) Tops Q2 Earnings and Revenue Estimates
CVRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in CVRx (CVRX): Can Its 19.0% Jump Turn into More Strength?
Strength Seen in Silk Road Medical (SILK): Can Its 24.0% Jump Turn into More Strength?
CVRx (CVRX) Stock Jumps 33.9%: Will It Continue to Soar?
Other News for CVRX
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Adaptive Biotechnologies (ADPT) and Rezolute (RZLT)
Lake Street Keeps Their Buy Rating on CVRx (CVRX)
Insider Buying Alert: President & CEO Kevin Hykes Acquires 30,000 Shares of CVRx Inc (CVRX)
CVRx Announces Increased Inpatient Payment for Barostim Procedure
CVRx announcs increased inpatient payment for barostim procedure